Outlook Therapeutics, Inc. (OTLK:NASDAQ) closed at $0.500 on October 15, 2026, up 6.34% on the day. The stock trades 80.3% below its 52-week high of $2.54 and 210.6% above its 52-week low of $0.161. Over the past year, it lost 62.7%. Outlook Therapeutics, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -14.54% | -26.14% | -63.77% | +35.14% | -62.69% |
In 252 trading sessions since October 15, 2025, OTLK closed higher on 107 days (42%). Its best day was May 27, 2026 (+46.50%) and its worst was January 2, 2026 (-58.23%). The stock moved 10% or more in a single session 44 times. It opened at least 5% above the previous day's high 6 times.
Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.
Find more stocks like OTLK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.